|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
-2.92/-2.40
|
企業價值
12.35M
|
資產負債 |
每股賬面淨值
-0.85
|
現金流量 |
現金流量率
--
|
損益表 |
收益
0
|
每股收益
0.04
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2024/06/01 02:29 EDT
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
Plus Therapeutics Inc is a clinical-stage pharmaceutical company. The company focuses on the discovery, development, and delivery of complex treatments for patients battling cancer and rare diseases. Its product pipeline includes Patented RNL and Patented DocePLUS. |